4baseCare is engaged in the development of affordable and accessible precision oncology solutions , using advanced genomics and next-generation digital health technology, to personalize patient care in oncology. We have developed unique set of comprehensive genomic panels which allow oncologists to chose the optimal targeted therapies for their patients.
All our efforts are channeled towards accelerating oncology research and creating affordable yet state-of-the-art solutions for cancer patients aimed towards improving clinical outcomes. We are devoted to the study of evidence retrieved from real-world settings and to understand malignancies, medicaments, therapies and cures.
With a presence in India and Singapore, 4baseCare is the first Asian healthcare organization backed by Illumina (the Global Genomics leader) through their Illumina Accelerator program.
4baseCare has also been selected for the 2nd Cohort of the AISEA accelerator (Sponsored by Department of Science & Technology, Govt. of India)
All our efforts are channeled towards accelerating oncology research and creating affordable yet state-of-the-art solutions for cancer patients aimed towards improving clinical outcomes. We are devoted to the study of evidence retrieved from real-world settings and to understand malignancies, medicaments, therapies and cures.
With a presence in India and Singapore, 4baseCare is the first Asian healthcare organization backed by Illumina (the Global Genomics leader) through their Illumina Accelerator program.
4baseCare has also been selected for the 2nd Cohort of the AISEA accelerator (Sponsored by Department of Science & Technology, Govt. of India)
Location: India
Employees: 51-200
Phone: +91 81051 71596
Total raised: $23.2M
Founded date: 2018
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.06.2026 | Series B | $13.37M | Infosys Te... |
| 30.01.2026 | Seed | $9.83M | Rebright P... |
Mentions in press and media 30
| Date | Title | Description |
| 21.07.2026 | Even Healthcare in talks to raise $50 million from Khosla Ventures, Alpha Wave | Synopsis The round will likely be at a valuation of about $300 million, nearly double that of $153 million it saw in its last funding round in January. The company decline to comment on the fundraise. Listen to this article in summarized fo... |
| 12.06.2026 | 4baseCare Accelerates Global Precision Oncology with $13.4 Million Funding | Precision oncology leader 4baseCare secured $13.4M in Series B funding. This capital fuels global genomics lab expansion and scales OncoTwin, its AI platform. The company targets diverse populations, decentralizing cancer diagnostics. It ai... |
| 11.06.2026 | Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform global | Synopsis Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform, OncoTwin. The company aims to make precision oncology inclusive for under-represented popu... |
| 11.06.2026 | Oncology startup 4baseCare closes Rs 128 Cr Series B round | Bengaluru-based precision oncology startup 4baseCare has closed its Series B funding round at Rs 128 crore, securing an additional Rs 38 crore in fresh capital led by growX Ventures, along with participation from existing investors. The com... |
| 11.06.2026 | Yali Capital-backed 4baseCare extends Series B round with a cheque from GrowX | (Photo by Thirdman, from Pexels) Precision oncology startup 4baseCare has secured an additional Rs 38 crore (nearly $4 million) as part of an extended Series B funding round, which included participation from new and existing investors. Thi... |
| 11.06.2026 | 4baseCare Bags ₹38 Cr To Close Series B Round At ₹128 Cr | SUMMARY The startup plans to continue deploying the freshly raised funds to fuel the expansion of its genomics laboratory globally and scale its AI-driven precision oncology platform Founded in 2018, 4baseCare leverages advanced genomics, b... |
| 12.03.2026 | Cent Leads AI Health Revolution: Early Disease Detection Secures Major Funding | Cent, a new healthtech startup, secures funding for its AI-driven early disease detection platform. Co-founded by Practo's Shashank ND, Cent targets critical conditions like cancer, cardiac, and metabolic diseases. It identifies these often... |
| 10.03.2026 | Healthtech startup Cent raised undisclosed funding from OneFlow, South Park Commons | OneFlow Holdings and South Park Commons have contributed an undisclosed sum of money to the healthtech startup Cent. Cent, which was founded by Practo founder Shashank ND, Arpit Garg (formerly of Lenskart), and Anshul Khandelwal (formerly o... |
| 30.01.2026 | [Weekly funding roundup Jan 24-30] Venture capital inflow sees sharp dip | The last week of January turned out to be disappointing for the Indian startup ecosystem as venture capital inflow dipped due to a lower number of deals and the absence of large value transactions. The total funding for the week came in at ... |
| 27.01.2026 | Ashish Kacholia, Lashit Sanghvi, Yali Capital invest Rs 90 crore in oncology startup 4baseCare | 4baseCare, a precision oncology startup building population-relevant clinico-genomic intelligence, today announced the first close of its Series B funding round, raising Rs 90 crore co-led by investors Ashish Kacholia, and Lashit Sanghvi wi... |
Show more